InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Riedel Norbert G, Director. Insider active across 6 companies, notably Eton Pharmaceuticals, Inc.. Aggregated, 19 reports have been logged. Split: 1 buy · 1 sell. Total volume traded: €361k. History available since 17 May 2021. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Riedel Norbert G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
1,605 股0Ordinary SharesSEC:0001161662-26-000005:0
12,500 股@ US$7.310.0094% mcap20.5% 占其流量Common StockSEC:0001437749-26-013041:0
3,415 股@ US$138.0840.2% 占其流量Ordinary SharesSEC:0001161662-26-000002:0
30,000 股@ US$4.420.014% mcap29.5% 占其流量Common StockSEC:0001437749-26-003230:0
3,507 股0Ordinary SharesSEC:0001765581-25-000082:0
27,400 股@ US$3.5820.1% 占其流量Common StockSEC:0001437749-25-000466:0
3,731 股0Ordinary SharesSEC:0001765581-24-000077:0
46,092 股Common StockSEC:0000950170-24-090806:0
10,461 股Common StockSEC:0000950170-24-070725:0
3,075 股0Ordinary SharesSEC:0001765581-23-000088:0
3,282 股Common StockSEC:0000899243-23-015179:0
8,000 股@ US$55.2856.9% 占其流量Ordinary SharesSEC:0001765581-22-000096:0
14,270 股Common StockSEC:0000899243-22-001199:0
100,000 股@ US$2.23100.0% 占其流量Common StockSEC:0001415889-21-005779:0
标准退出：2022年3月6日 (T+90)
1,306 股@ US$147.9616.4% 占其流量Ordinary SharesSEC:0001765581-21-000108:0
2,246 股0Ordinary SharesSEC:0001765581-21-000081:0
380,000 股0Common StockSEC:0001415889-21-002619:0
380,000 股0Common StockSEC:0001415889-21-002573:0
12,500 股Common StockSEC:0001127602-16-039325:0
19 条申报中的 19 条
About Riedel Norbert G
RIEDEL NORBERT G is Director at Jazz Pharmaceuticals plc, Cerevel Therapeutics Holdings, Inc., Eton Pharmaceuticals, Inc. and ARIAD PHARMACEUTICALS INC, and CEO at Aptinyx Inc. The declarant has 18 filings in total, and in the sampled recent filings the buy volume is EUR 197261 and the sell volume is EUR 163265, over the period from 2016-02-03 to 2026-04-22; the modal transaction nature is Option exercise.
